ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0050
-0.0005 (-9.09%)
Sep 17, 2026, 12:24 PM AEST
ImpediMed Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, ImpediMed stock has a consensus rating of "Buy" and an average price target of $0.02. The average 1-year stock price forecast is 300.00% higher than the current stock price, while the lowest is $0.01 (+100.00%) and the highest is $0.04 (+700.00%).
Price Target: $0.02 (+300.00%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ImpediMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgans | Morgans | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Aug 31, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $0.01 | Buy | Maintains | $0.01 | +100.00% | Aug 27, 2026 |
| Ord Minnett | Ord Minnett | Buy Maintains $0.05 → $0.02 | Buy | Maintains | $0.05 → $0.02 | +300.00% | May 12, 2026 |
Financial Forecast
Revenue This Year
20.56M
from 14.61M
Increased by 40.66%
Revenue Next Year
27.58M
from 20.56M
Increased by 34.18%
EPS This Year
-0.00
from -0.01
EPS Next Year
-0.00
from -0.00
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.